Anthrax — Precision Vaccinations News

Fact checked by Robert Carlson, MD

Oct 23

3 min read

Next-Gen Anthrax Vaccine To Launch Phase 1 Study

BlueWillow Biologics BW-1010 is an intranasal anthrax vaccine candidate

laboratory

Fact checked by Robert Carlson, MD

Aug 1

4 min read

BARDA Exercises $261 Million Dollar Option for Innovative Anthrax Vaccine

Emergent BioSolutions AV7909 anthrax vaccine being added to the Strategic National Stockpile

Man in bio hazard wuit and gas mask

Fact checked by Robert Carlson, MD

Jun 29

5 min read

2nd Anthrax Case Confirmed in Texas Animals

Anthrax vaccine and medications reduce illness and mortality risks from anthrax

antelope grazing

Fact checked by Robert Carlson, MD

Jun 5

4 min read

Anthrax Vaccine Candidate NanoVax Awarded Patent

BlueWillow’s NanoVax vaccine platform employs a novel oil-in-water emulsion adjuvant that elicits both systemic and mucosal immunity

willow buds against the blue sky

Fact checked by Robert Carlson, MD

May 17

3 min read

BARDA to Purchase Anthrax Vaccine for Strategic Stockpile

Emergent Anthrax Vaccine AV7909 consists of Anthrax Vaccine Adsorbed drug substance and CPG 7909 adjuvant

terror training